| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.19B | 27.48B | 24.75B | 28.11B | 20.96B | 17.07B |
| Gross Profit | 18.98B | 17.25B | 14.87B | 17.98B | 10.14B | 8.56B |
| EBITDA | 17.22B | 16.16B | 14.03B | 16.76B | 9.21B | 8.66B |
| Net Income | 8.18B | 6.83B | 6.95B | 7.31B | 4.15B | 3.57B |
Balance Sheet | ||||||
| Total Assets | 221.42B | 212.72B | 190.14B | 177.49B | 158.94B | 140.91B |
| Cash, Cash Equivalents and Short-Term Investments | 2.00B | 2.81B | 1.49B | 2.69B | 1.60B | 639.00M |
| Total Debt | 10.46B | 95.62B | 82.33B | 73.21B | 64.97B | 54.83B |
| Total Liabilities | 154.79B | 146.24B | 129.28B | 118.47B | 109.50B | 95.24B |
| Stockholders Equity | 55.22B | 54.61B | 50.10B | 47.47B | 39.23B | 37.20B |
Cash Flow | ||||||
| Free Cash Flow | 2.36B | 3.21B | 4.75B | 1.75B | -1.48B | -277.00M |
| Operating Cash Flow | 12.33B | 12.48B | 13.26B | 11.30B | 8.26B | 7.55B |
| Investing Cash Flow | -26.96B | -23.86B | -22.26B | -23.47B | -18.36B | -13.59B |
| Financing Cash Flow | 14.55B | 12.98B | 7.00B | 12.15B | 12.23B | 5.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $73.23B | 16.71 | 12.06% | 3.25% | 10.46% | 19.64% | |
79 Outperform | $198.69B | 22.23 | 13.05% | 2.84% | 11.51% | 47.33% | |
71 Outperform | $99.04B | 18.33 | 9.69% | 3.61% | 6.19% | 11.06% | |
66 Neutral | $105.39B | 22.16 | 12.50% | 3.40% | 10.58% | -1.88% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
59 Neutral | $47.99B | 15.92 | 9.87% | 3.68% | 5.34% | 11.60% | |
56 Neutral | $55.01B | 16.69 | 10.77% | 4.59% | 16.62% | 27.30% |